Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
ERASE is part of the MyeloMATCH initiative, Young Adult Basket and is a Tier 2 study. The study is comparing the use of Cytarabine to Cytarabine and Venetoclax, Daunorubicin/Cytarabine Liposome and Venetoclax, and Azacitidine and Venetoclax.
Epistemonikos ID: abb5eb6e465d5995e3aeaa273eed743f2242ef49
First added on: May 14, 2024